Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer

Volume: 26, Issue: 2, Pages: 305 - 313
Published: Aug 11, 2021
Abstract
Transmembrane serine protease 4 (TMPRSS4) belongs to the family of type II transmembrane serine proteases that are known to be upregulated in many malignant tumors. However, there is a paucity of studies documenting the clinical impact and biological effects of TMPRSS4 on gastric cancer (GC) patients who underwent surgery.Tissues samples were obtained from 105 patients with GC who underwent gastrectomy followed by adjuvant chemotherapy,...
Paper Details
Title
Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
Published Date
Aug 11, 2021
Volume
26
Issue
2
Pages
305 - 313
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.